Eton Pharmaceuticals, Inc. Purchase Agreements
7 Contracts & Agreements
- Asset Purchase Agreement by and among the Company and Dr. Reddys Laboratories S.A., dated as of June 24, 2022 (Filed With SEC on August 11, 2022)
- Purchase Agreement dated March 26, 2020 by and among the Company and Certain Investors (Filed With SEC on March 30, 2020)
- Securities Purchase Agreement dated March 26, 2020 by and between the Company and Opaleye L.P (Filed With SEC on March 30, 2020)
- Asset Purchase Agreement (DS-200) dated June 23, 2017 between Selenix, LLC and the Registrant (Filed With SEC on August 10, 2018)
- Asset Purchase and License Agreement (CT-200) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant (Filed With SEC on August 10, 2018)
- Asset Purchase and License Agreement (CT-100) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant (Filed With SEC on August 10, 2018)
- Securities Purchase Agreement dated June 19, 2017 by and among the Registrant and the Buyers named therein (Filed With SEC on August 10, 2018)